Announcement: Crown Aesthetics’ UKI Sales Team to be led by Director of Sales, UKI, Simon Ofei

December 16, 2022 (Dallas, TX). Crown Aesthetics (“Crown”), a division of Crown Laboratories, Inc., is excited to announce Simon Ofei will join the organization as Director of Sales, United Kingdom & Ireland from 2023, January 3rd to support Crown’s UKI commercial efforts and further develop the SkinPen® Precision business, along with 2023 new product launches.

With over 25 years’ experience spanning the pharmaceutical and medical aesthetic industry with the last 5 years spent as the Country Head UKI at Sinclair, Mr. Ofei is an exceptional sales leader. ‘I always aim to achieve the company’s strategic goals and I have a huge passion for people development. Personally, I love to travel with my family, and I am also massive fan of the Leeds Rhinos rugby league team!’

Simon has demonstrated remarkable ability in sales, training, education, employee coaching and development. ‘I am super excited to be joining Crown Aesthetics as it is already gaining great traction in the UKI market, with a strong reputation for SkinPen® Precision along with superb customer service by the sales, marketing and training team. My aim is to accelerate the sales growth in the UKI and also to help develop our people. I am thrilled to be taking up this new role in 2023.’

“By strengthening our UKI sales team, we will help the practices grow by driving patient demand,” said Andy Moulton, Vice President of Sales, International for Crown Aesthetics. “With Simon leading the way, customers can be assured that they will receive the same superior level of Excellence in training, education, marketing and customer service they deserve.”

Launched in 2013 and backed by over 90 validation studies*, SkinPen Precision is the first microneedling device cleared by the FDA. Superior US engineered and manufactured, SkinPen® Precision is considered as the global Gold Standard for Skin Remodelling and commercialized in 42 countries in the world.